Sign up to save your podcasts
Or
Share E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo. I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum!
View all episodes
By Michael Putman
4.9
111111 ratings
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo. I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum!
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
315 Listeners
JAMA Clinical Reviews
497 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,328 Listeners
Core IM | Internal Medicine Podcast
1,105 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
516 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Freely Filtered, a NephJC Podcast
168 Listeners
ACR on Air
70 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
174 Listeners
Talking Rheumatology Spotlight
6 Listeners
ACR Journals On Air
19 Listeners